Earnings Feed
Start Free
|4Jan 19, 5:22 PM ET

Frelick Jeff 4

4 · Bone Biologics Corp · Filed Jan 19, 2024

Insider Transaction Report

Form 4
Period: 2024-01-17
Bone Biologics CorpBBLG
Frelick Jeff
Chief Executive Officer
Transactions
  • Award

    Employee Stock Option

    2024-01-17+25,000→ 25,000 total
    Exercise: $3.61From: 2024-01-17Exp: 2026-01-17→ Common Stock (25,000 underlying)
Holdings

  • Common Stock

    2,151

  • Employee Stock Option

    Exercise: $9540.00Exp: 2025-12-27→ Common Stock (173 underlying)
    173

  • Employee Stock Option

    Exercise: $12300.00Exp: 2026-05-26→ Common Stock (44 underlying)
    44

  • Employee Stock Option

    Exercise: $892.80Exp: 2025-01-01→ Common Stock (208 underlying)
    208

  • Employee Stock Option

    Exercise: $57.60Exp: 2025-01-25→ Common Stock (157 underlying)
    157
Footnotes (2)
  • [F1]This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately.
  • [F2]This option is fully vested as of the date of this report.

Documents

1 file
  • 4
    ownership.xmlPrimary